title: Spectrum of cardiac tumors excluding myxoma: Experience of a tertiary center with review of the literature.
abstract: The aim of this study was to determine the histological spectrum of operated cardiac tumors, excluding myxoma, at a tertiary center in India. Between 1995 and 2010, we encountered 188 cases of operated cardiac tumors that had been subjected to histopathological examination. Morphological characterization was done by light microscopy along with histochemical stains. Immunohistochemistry using a panel of antibodies, i.e., vimentin, desmin, myogenin, smooth muscle actin (SMA), epithelial membrane antigen (EMA), cytokeratins, factor VIII-related antigen, S100-protein, synaptophysin, chromogranin, Bcl2, MIB-1, leukocyte common antigen (LCA), CD 3, CD20, CD34, and CD 99 (MIC-2) was performed wherever applicable. Out of the 188 cases, 184 were primary cardiac tumors, including 170 cases of benign cardiac tumors. Among the benign tumors, myxomas were the most frequent ones (168 cases), followed by fibroma (2 cases). Primary malignancy was diagnosed in 14 cases, including undifferentiated sarcomas, primitive neuroectodermal tumor, rhabdomyosarcoma non-Hodgkin lymphoma, angiosarcoma, synovial sarcoma, and leiomyosarcoma. Metastatic (secondary) tumors were seen in four cases, including one each of adenocarcinoma, choriocarcinoma, renal cell carcinoma, and alveolar soft part sarcoma. Hence, out of the total of 188 cases, 20 were non-myxoma cardiac tumors (NMCTs), including 2 benign tumors, 14 malignant tumors, and 4 metastatic tumors. In our series, the majority of cardiac tumors were primary in nature. The malignant primary tumors outnumbered benign ones, excluding myxomas, and the most common malignant histology was undifferentiated sarcoma, as opposed to the literature.
authors.affiliation: Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. rumasrc2@hotmail.com
authors.forename: Narender
authors.initials: N
authors.lastname: Kumar
authors.forename: Shipra
authors.initials: S
authors.lastname: Agarwal
authors.forename: Arvind
authors.initials: A
authors.lastname: Ahuja
authors.forename: Prasenjit
authors.initials: P
authors.lastname: Das
authors.forename: Balram
authors.initials: B
authors.lastname: Airon
authors.forename: Ruma
authors.initials: R
authors.lastname: Ray
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor; D002648:Child; D002675:Child, Preschool; D005260:Female; D005350:Fibroma / Q000453:epidemiology / Q000473:pathology; D006338:Heart Neoplasms / Q000453:epidemiology / Q000473:pathology*; D006394:Hemangiosarcoma / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007194:India; D007890:Leiomyosarcoma / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009232:Myxoma / Q000453:epidemiology; D018242:Neuroectodermal Tumors, Primitive / Q000473:pathology; D012208:Rhabdomyosarcoma / Q000473:pathology; D012509:Sarcoma / Q000473:pathology; D013584:Sarcoma, Synovial / Q000473:pathology; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor